The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke.

@article{Elkind2010TheLO,
  title={The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke.},
  author={Mitchell S. V. Elkind and Jorge M. Luna and Christopher S. Coffey and Leslie A. McClure and Khin M Liu and Steven L Spitalnik and Myunghee Cho Paik and Ana Elena Guerrero Rold{\'a}n and Carole White and Rachel Hart and Oscar R. Benavente},
  journal={International journal of stroke : official journal of the International Stroke Society},
  year={2010},
  volume={5 2},
  pages={117-25}
}
BACKGROUND Inflammation is increasingly recognised as playing a central role in atherosclerosis, and peripheral blood markers of inflammation have been associated with incident and recurrent cardiac events. The relationship of these potentially modifiable risk markers to prognosis after ischaemic stroke is less clear. The Levels of Inflammatory Markers in the Treatment of Stroke (LIMITS) study will address hypotheses related to the role of inflammatory markers in secondary stroke prevention in… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 92 references

: the Northern Manhattan Study

  • MA Hlatky, P Greenland, D Arnett
  • 2007

Similar Papers

Loading similar papers…